Zacks Research Upgrades Accendra Health (NYSE:ACH) to “Hold”

Accendra Health (NYSE:ACH) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Tuesday,Zacks.com reports.

Separately, Weiss Ratings assumed coverage on Accendra Health in a research note on Wednesday, April 8th. They issued a “sell (e+)” rating for the company. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Reduce”.

Accendra Health Price Performance

Shares of Accendra Health stock opened at $3.45 on Tuesday. Accendra Health has a fifty-two week low of $1.84 and a fifty-two week high of $9.55. The company has a market capitalization of $263.72 million, a P/E ratio of -0.24, a P/E/G ratio of 2.71 and a beta of 1.27.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.